Chemogenics Biopharma Llc Headquarters
Looking for information about Chemogenics Biopharma Llc Headquarters? The links below have collected all the necessary data.
ChemoGenics Biopharma LLC North Carolina Biotech Center
- https://directory.ncbiotech.org/company/chemogenics-biopharma-llc
- ChemoGenics BioPharma provides collaborative drug discovery, bioanalytical, formulation and scale-up services. Capabilities include medicinal chemistry, DMPK, bioinformatics and preclinical models in cancer, inflammation and metabolic diseases. Company Location. https://www.chemogenicsbiopharma.com. 104 T.W. Alexander Drive, Building 7.
Chemogenics Biopharma Durham NC, 27709 – Manta.com
- https://www.manta.com/c/mtcc5gw/chemogenics-biopharma-llc
- Chemogenics Biopharma, LLC; 104 Tw Alexander Drive # 7; Durham, NC 27709 (919) 323-8133 ... Similar Businesses. Detailed Information. Location Type Headquarters; Year Established 2009; Annual Revenue Estimate 660585; SIC Code show 2834, Pharmaceutical Preparations; NAICS Code show 325412, Pharmaceutical Preparation Manufacturing; Employees 8 ...Employees: 8
ChemoGenics BioPharma LinkedIn
- https://www.linkedin.com/company/chemogenics-biopharma
- ChemoGenics BioPharma 77 followers on LinkedIn. Contribution to design and synthesis of Phase 2 Clinical Compounds: Trilaciclib and Lerociclib ChemoGenics BioPharma excels in multiple phases of ...Founded: 2008
Chemogenics Biopharma, LLC in Durham, NC Company Info ...
- https://www.bizapedia.com/nc/chemogenics-biopharma-llc.html
- Chemogenics Biopharma, LLC is a North Carolina Domestic Limited-Liability Company filed On September 3, 2008. The company's filing status is listed as Current-Active and its File Number is 1061300 . The Registered Agent on file for this company is Tavares, Francis X, and is located at 923 Bluestone Road, Durham, NC 27713.Founded: Sep 03, 2008
Have you found Chemogenics Biopharma Llc Headquarters information?
On our site you can find many other information about headquarters of any company. Research information about other companies.